Flynn has been directly involved in the field of ADHD for over fourteen years.
ADHD is a behavioural syndrome characterized by hyperactivity, impulsivity, and inattention. It frequently goes undiagnosed and is commonly misunderstood. Today ADHD is firmly recognised as a lifelong condition, and while previously believed to be associated exclusively with childhood, it is clear that the condition can persist, or emerge in adulthood, continuing to present unique challenges for the individual, often with detrimental effects on their personal outcomes.
Upcoming Events
Flynn Pharma is committed to the delivery of high quality educational events that support the continued development of healthcare professionals – it's our way of helping you to help your patients.
Don't miss out. Throughout 2023 and going forward, Flynn will host a series of educational events that are free to attend. Sign up to receive details of our latest updates.
Forensic Aspects of ADHD
Register for our ADHD webinar where we will be focusing on challenges associated with identifying, managing, and treating ADHD within the forensic environment and to discuss the pharmacotherapy options available. Joined by Dr Rick Bunn, an expert in Forensic Psychiatry.
Wednesday 3 December 2025 at 13:00
North West Neurodevelopmental Study Day
Join us at this in-person study day where we will be exploring a wide range of topics including: optimising melatonin prescribing, managing sleep difficulties in children, and how to help children swallow pills. We will be joined by experts Dr Mischa Mockett, Dr Joe Johnson, Rachel Rowley, Dr Luisa Sanz-Villanueva and Dr Alice McCloskey.
Thursday 15 January 2026 at 09:00
Become an NDD Community Member
Join our community as a Member and keep up to date on the latest developments.
Education & Training
Flynn works across a number of complex yet treatable therapy areas and is committed to supporting the continued education of healthcare professionals, trainees and allied roles.
Information for Parents of Children Prescribed Meflynate® XL (Methylphenidate Hydrochloride)
Information for parents of children prescribed Meflynate XL - a general guide to treatment with Meflynate XL.
How to Make a Move to Secondary School
Support for children with ADHD moving to secondary school, providing tips for children and parents to make this change as easy as possible.
ADHD and ASD
Information for parents of children who may have characteristics or symptoms suggestive of ADHD and/or ASD.
Request a meeting
Send a virtual meeting request
Service Support
Flynn has collaborated with clinicians and leaders working within the NHS and the third sector to create a range of patient-focused resources and materials designed to improve decision-making and support service improvement across a number of therapy areas.
An Integrated Care Pathway document for the management of ADHD patients throughout their ADHD journey. Created in ...
Despite its prevalence, ADHD in adults often goes unrecognised and remains under-diagnosed. Inspired by Dr ...